Search Results

You searched for : EuropeanMedicinesAgency  

Pfizer and BioNTech to supply the European Union with 100 million additional doses of COVID vaccine

COMIRNATY will be produced in BioNTech’s and Pfizer’s manufacturing sites in Europe ...
Apr 20

Germany and Canada limits use of AstraZeneca vaccine

Germany restricts the vaccine for those over 60 while Canada restriction at 55 years and older...
Mar 31

Tessa Therapeutics receives PRIME designation from EMA for CD30 CAR-T Therapy

Tessa announced, EMA has granted PRiority MEdicines designation to the company's lead autologous CD30 CAR-T therapy for the treatment of relapsed or refractory ...
Jan 19

PFIZER’S XALKORI APPROVED BY USFDA FOR ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA IN CHILDREN AND YOUNG ADULTS

XALKORI is the first biomarker-driven therapy for relapsed or refractory ALCL in young people ...
Jan 15

WuXi Biologics receives GMP certification from Brazil's ANVISA

The positive assessment from ANVISA reaffirms WuXi Biologics' strong commitment to offering partners a global manufacturing network of the highest standard...
Dec 28

EU approves Pfizer-BioNTech's corona vaccine for use in 27 nation grouping

EU mass vaccination programme to roll out soon...
Dec 22

Fortress Biotech announces US FDA has granted breakthrough therapy designation for CUTX-101

Fortress Biotech declares US FDA has granted breakthrough therapy designation for CUTX-101, Copper Histidinate, for the treatment of Menkes Disease ...
Dec 16

USFDA approves Roche’s OCREVUS shorter 2-hour infusion for relapsing and primary progressive multiple sclerosis

Shorter infusion time will further improve the twice-yearly treatment experience for OCREVUS, the only B-cell therapy for relapsing and primary progressive MS with ...
Dec 15

CHMP recommends approval of Plavix with aspirin in adults for certain types of strokes

CHMP issues positive opinion for use of Plavix with aspirin in adults within 24 hours of minor ischemic stroke or high-risk transient ischemic attack ...
Dec 12

ReAlta Life Sciences Announces EMA Orphan Drug Designation for RLS-0071 for the Treatment of Neonatal Encephalopathy

The EMA grants orphan status to medicinal products intended to treat rare disorders that affect fewer than 5 people per 10,000 in the European ...
Dec 04

BioNTech and Fosun Pharma receive approval to commence COVID-19 Vaccine Candidate BNT162b2 trial in China

BNT162b2 is currently in Phase 3 clinical trials in the United States, Germany, Argentina, Brazil, South Africa, Turkey and other countries...
Nov 20

Janssen submits new drug application to U.S. FDA for treatment of schizophrenia in adults

...
Nov 02

Janssen submits new drug application to U.S. FDA for treatment of schizophrenia in adults

...
Nov 02

AbbVie submits regulatory applications to US FDA and EMA for RINVOQ (upadacitinib) in atopic dermatitis

These submissions are an important step forward in the commitment to providing an additional treatment option ...
Oct 20

Sobi announces topline phase 3 data of avatrombopag for the treatment of Chemotherapy

...
Oct 09

Pfizer announces FDA approval of oncology supportive care Biosimilar , NYVEPRIA

NYVEPRIA is indicated to decrease the incidence of infection, as manifested by febrile neutropenia...
Jun 17

16 Matching result(s) found!

-Advertisements-




Trending Now

Why are key populations on the blindspot in the global HIV response?July 20, 2024
Exploring the Link Between Tinnitus and Body Composition: What Recent Research RevealsJuly 20, 2024
Surge in Brain Infections in India During Monsoon: A Growing ConcernJuly 20, 2024
We have more infection-prevention options now but are they actual choices for the people?July 19, 2024
New humidity-driven membrane to remove carbon dioxide from the airJuly 19, 2024
Introducing the World's First Consent-Based Data-Sharing Framework Built on Open Standards: The Affinidi Iota Framework July 19, 2024
The Power of Green Spaces: Evidence That Parks May Delay Cognitive DeclineJuly 19, 2024
Strengthening Healthcare in India: The Push for Better Coverage with Ayushman BharatJuly 19, 2024
SARV Events & Celebrations Shines at "Edu-Bizz Leadership Summit & Awards 24July 18, 2024
UAE launches global initiative to build 10 hospitals to address critical healthcare gaps as part of Zayed Humanitarian Legacy InitiativeJuly 18, 2024
Geetanjali Homestate Expands Global Presence with the Launch of Geetanjali GlobalJuly 18, 2024
Changes projected in marine fish communities due to climate changeJuly 18, 2024
Understanding the Chandipura Virus Outbreak in Gujarat: A Critical OverviewJuly 18, 2024
Landmark Study Links Severe Endometriosis to Increased Risk of Ovarian CancerJuly 18, 2024
Equipping Healthcare Professionals for Global Opportunities: GIMS Partners with NSDCJuly 18, 2024
Hormone Modulating Therapy for Breast Cancer and Its Link to Lower Alzheimer’s RiskJuly 18, 2024
Multipl Secures $1.5 Million in Additional Funds, Led by Blume Ventures and MIXI Global Investments, JapanJuly 17, 2024
FedEx to empower youth with digital skilling programJuly 17, 2024
Putting people first means following Gandhi's TalismanJuly 17, 2024
American Oncology Institute (AOI) Launches #BreaktheHabit Campaign to Raise Awareness on Head & Neck cancerJuly 17, 2024